May 312007
 

Ms. Magazine has long had a page at the end with ads that are blatantly sexist that they call No Comment.  In the same genre, here are 2 ads,  worthy of inclusion, but what the hell, call these folks and comment:

Andi Zeisler posted this on WIMN’s Voices:

Bitch reader Amy Pitts wrote in with a heads up on a new ad campaign from fancy messenger-bag peddler Timbuk2 that appears to play the rape of a teen for big yuks. Featuring a tear-stained, prom-dressed blond on one side of the page and a greasy, bewifebeatered guy on the left, the copy reads “Just like that jerk who stole your virginity, these bags are only around for a short time.?

customerservice@timbuk2.com or pr@timbuk2.com or call them  at 1-800-865-2513.

And then there is a billboard in Glenview, IL that Christine C. flagged on Our Bodies Our Blog:

“a 10-foot-by-36-foot billboard advertisement for a local spa showing a supposedly flawless model lying on the beach with text identifying potential “problem” areas such as “cellulite and saddlebags” and “facial lines and wrinkles” along with “solutions” like “botox” and “lipodissolve.””

Unfortunately there is no contact info for these folks, but it’s probably findable on the web (but I’m running out the door, so you’re on your own).

Share
 May 31, 2007  Posted by on May 31, 2007 Comments Off
May 312007
 

http://www.malalaijoya.com/index800.htm
Defense Committee for Malalai Joya, May 29, 2007
Hundreds of women protest in Pul-e-Khumri against suspension of Joya

Demonstrators demanded the immediate reinstatement of Joya

Hundreds of women and girls staged protest rally in Pul-e-Khumri city of Baghlan province in north of Afghanistan. They voiced their support to Malalai Joya. Demonstrators demanded the immediate reinstatement of Joya who was ousted on may 21.
Continue reading »

Share
 May 31, 2007  Posted by on May 31, 2007 Comments Off
May 302007
 

Call me cynical but…

According to Health Day,

“Premenopausal women who get a lot of vitamin D and calcium may cut their risk of breast cancer by almost a third, Harvard Medical School researchers report.”

Studies in animals have found similar results.  So maybe pre-menopausal women should get more calcium and vitamin D? Not so according to American Cancer Society epidemiologist Victoria Stevens,

“I really don’t think that one can say from this study that the effect is only in premenopausal women, because there are a number of factors in the study that may have limited the ability to see the effect,” said Victoria Stevens, an epidemiologist at the American Cancer Society. “This is particularly true for vitamin D, because most vitamin D comes from exposure to sunlight, which they did not take into account.”

Um, given that the downside of taking vitamin D and calcium are  minimal, this seems peculiar coming from ACS, an organization that has no qualms about recommending chemotherapy that only helps a small percentage of those treated and has quite a few side effects and mammography which involves radiation, which is known absolutely to cause cancer and for which there is no safe level of exposure.  But I guess the vitamin D ad calcium lobbies don’t fork up as much money as the pharmaceuticals and manufacturers of mammogram equipment do.

Share
 May 30, 2007  Posted by on May 30, 2007 Comments Off
May 272007
 

Should you take drugs to treat osteoporosis?  Maybe, but…

“As you hear about new treatments for osteoporosis, question the sources of the information you receive. They may have ties to corporate interests that stand to gain by increasing women’s fears of illness and disease.”

Judy Norsigian and Heather Stephenson offer a few facts about the available drugs that you won’t hear in the glitzy commercials,

“Other medications are now prescribed more often to treat postmenopausal osteoporosis. These include the bisphosphonates known as alendronate (brand name Fosamax), risedronate (Actonel) and ibandronate (Boniva); the hormone calcitonin (Miacalcin or Fortical); and a selective estrogen receptor modulator called raloxifene (Evista).

Continue reading »

Share
 May 27, 2007  Posted by on May 27, 2007 Comments Off
May 272007
 

Press Release:
Judicial Watch Uncovers Three Deaths Relating to HPV Vaccine

Event Reports Obtained from FDA Detail 1,637 Adverse Reactions to Gardasil

(Washington, DC) — Judicial Watch, the public interest group that investigates and prosecutes government corruption, today released documents obtained from the U.S. Food and Drug Administration (FDA) under the provisions of the Freedom of Information Act, detailing 1,637 reports of adverse reactions to the vaccination for human papillomavirus (HPV), Gardasil. Three deaths were related to the vaccine. One physician’s assistant reported that a female patient “died of a blood clot three hours after getting the Gardasil vaccine.? Two other reports, on girls 12 and 19, reported deaths relating to heart problems and/or blood clotting.

As of May 11, 2007, the 1,637 adverse vaccination reactions reported to the FDA via the Vaccine Adverse Event Reporting System (VAERS) included 371 serious reactions. Of the 42 women who received the vaccine while pregnant, 18 experienced side effects ranging from spontaneous abortion to fetal abnormities.

Continue reading »

Share
 May 27, 2007  Posted by on May 27, 2007 Comments Off